• Link to X
  • Link to Facebook
  • Link to Instagram
  • Link to TikTok
  • Link to Youtube
  • About
    • About Us
      • President
      • Board of Directors
      • Board of Advisors
      • Financials
      • Our Methodology
      • Success Tracker
      • Contact
  • Act Now
    • 30 Ways to Help
      • Email Congress
      • Call Congress
      • Volunteer
      • Courses & Certificates
      • Be a Donor
    • Internships
      • In-Office Internships
      • Remote Internships
    • Legislation
      • Politics 101
  • The Blog
  • The Podcast
  • Magazine
  • Donate
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Archive for category: Health

Information and stories on health topics.

Developing Countries, Global Poverty, Health

Poverty and Antibiotic Resistance in Southeast Asia

Antibiotic Resistance in Southeast Asia
In September 2016, the United Nations General Assembly (UNGA) declared antimicrobial resistance (AMR) a major health threat for nations in every part of the world. AMR comes about when bacteria evolve to resist antibiotics used for the treatment of many infectious diseases such as pneumonia, tuberculosis and salmonellosis. According to the Center for Disease Control and Prevention (CDC), AMR can bring harm to people of all types and agriculture, health care and veterinary industries. Antibiotic resistance in Southeast Asia is of particular concern. 

Antibiotics have been essential to curing infections ever since Alexander Fleming discovered the first form of antibiotics, penicillin, in 1928. In the developing countries of Southeast Asia, antibiotics often do not have regulation and are available for purchase without a prescription from a physician, which exacerbates the phenomenon of AMR and causes major concern. This is an example of how poverty in Southeast Asia contributes to the antibiotic resistance crisis.

Contributions to Antimicrobial Resistance

AMR is a natural process. With or without the use of antibiotics, bacteria will always evolve to fight for survival by strengthening their resistance or by multiplying. Despite this, humans make AMR worse. A plethora of unnatural issues exaggerates AMR, but there are two that are cause for the greatest concern: unregulated sale of antibiotics and the use of antibiotics not as medicine for humans but as growth promoters and disease treatments in livestock. 

Unregulated Antibiotics and Self Medication in Southeast Asia

The World Health Organization Southeast Asia Region (WHO SEAR) includes the countries of Bangladesh, Bhutan, Democratic People’s Republic of Korea, India, Indonesia, Maldives, Myanmar, Nepal, Sri Lanka, Thailand and Timor-Leste. These countries are notorious for selling antibiotics as an unregulated product to the public, a reality of many developing countries around the world. In developing countries, the prevalence of infectious deadly diseases is higher than in more developed nations, making the likelihood of death from these issues higher.

Many consider the countries in Southeast Asia listed above to be hotspots for the spread of AMR. Here, the cost of antibiotics bought over the counter is lower than the cost to visit a physician or health professional. As a result, many self-medicate, making it the leading cause of AMR. Self-medication refers to the use of medication to treat ailments, diseases or infections without the guidance of a medical professional. Without curbing this habit practiced in WHO SEAR, bacteria quickly mutate to resist treatment, leading to more intense illnesses, increased medication prices and death. 

The Use of Antibiotics for Livestock in Southeast Asia

In this region, the use of antibiotics in livestock outweighs the use of antibiotics in humans. To keep livestock in countries around the world healthy, farmers commonly use antimicrobials to treat and prevent diseases and decrease mortality in livestock. Though people widely practice this, the countries of WHO SEAR use this technique excessively due to poverty. With weak regulatory laws to govern or survey the effects this has on the AMR crisis, AMR is aggressively growing. 

Where previously people ignored it when considering the causes of AMR, livestock antibiotic use has recently become a growing concern across the globe. With recognition came complication: in developing countries, farmers rely on the use of antibiotics to prevent illness or death of their animals so they can continue to make a profit. In Southeast Asia especially, the hard reality is that these issues layer and mix with other issues, such as poverty and food security. Policies regarding antimicrobial consumption in livestock that work for developed nations often do not work in underdeveloped nations, due to the complex differences of cultural differences and locations. It is for these reasons that poverty contributes to antibiotic resistance in Southeast Asia.

Efforts to Slow Antibiotic Resistance in Southeast Asia

Given that this crisis is on a global scale and affecting every nation, some are making efforts to control AMR. Unfortunately, there is no way to stop it completely. There are, however, the WHO’s action plans that can bring light to this topic. WHO has laid out five strategic goals: to increase recognition and understanding of AMR, to increase global monitoring and research, to decrease the prevalence of infectious diseases requiring antibiotic treatment, to improve the use of antibiotic treatment and to create a case for sustainable investment that includes all nations, no matter location or level of development

An example of raising awareness is World Antibiotic Awareness Week. Every year brings the annual World Antibiotic Awareness Week, created by the WHO in 2015. This week in November sets goals to increase awareness and encourage health care providers, policymakers and the public to practice healthy and sustainable techniques to slow the spread of antibiotic resistance in Southeast Asia.

– Anna Giffels
Photo: Flickr

September 17, 2019
https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg 0 0 Kim Thelwell https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg Kim Thelwell2019-09-17 01:30:172024-05-29 23:10:26Poverty and Antibiotic Resistance in Southeast Asia
Disease, Health

Cholera: Health Crisis in Yemen

Cholera Health Crisis in Yemen
A massive resurgence of cholera afflicts Yemen, a bacterial infection that can kill within hours if untreated. Between January 2018 and June 2019, reports have determined there have been about 800,000 cases of cholera in the country. Here is a breakdown of the cholera health crisis in Yemen and the response from four notable organizations.

What is Cholera?

Cholera is a potentially fatal bacterial infection that can cause diarrhea, severe dehydration, nausea and vomiting. It mainly spreads through the consumption of water and food contaminated with the bacterium Vibrio cholerae.

Industrialized countries with proper water sewage filtration systems are unlikely to experience surges of cholera outbreaks. However, countries with inadequate water treatment are at a much higher risk of experiencing a cholera epidemic. Areas afflicted by natural disasters, poverty, war and refugee settings are at an exacerbated risk of experiencing cholera outbreaks.

The oral cholera vaccine is highly effective but the vaccine was not available in Yemen prior to the epidemic outbreak in 2017. Since then, more than 300,000 Yemenis received the cholera vaccination but continuous conflict provides a barrier between health care officials and the rest of the population. Doctors Without Borders maintains that the vaccine, while highly effective, is not enough to end cholera due to its low supply and short term protection.

Cholera Health Crisis in Yemen

As Yemen faces its fourth year of war, the country also fights a looming health crisis. The cholera health crisis in Yemen affects 22 of 23 governorates and almost 299 of Yemen’s 333 districts. Recording over one million cholera cases in 2017, Yemen’s crisis is the worst cholera epidemic on record.

Driven by years of war, the country has experienced a significant collapse in access to food, safe drinking water and health care. With millions of Yemenis facing famine, malnourishment increases the risk of cholera infections becoming fatal.

Many organizations are on the ground in Yemen, treating as many cholera cases as possible. Organizations responding to the health crisis in Yemen include Médecins Sans Frontières (MSF) or Doctors Without Borders, Save the Children, Islamic Relief Foundation and World Health Organization (WHO).

If left untreated, the mortality rate of cholera can be very high. With proper treatment, cholera is very easy to cure. The problem is that it is not easy for cholera victims to get to a medical center quickly, especially amidst times of war. One MSF treatment center in the governorate of Khamer explains the hardship that increasing fuel prices pose on those seeking health care.

During the peak of the cholera health crisis in Yemen, MSF treated over 100,000 patients with cholera. The use of cholera kits, essentials to treat the infection, allows the charity to respond quickly and effectively to any cholera outbreak. MSF also has cholera treatment centers in the heart of areas with cholera outbreaks.

Since cholera can lead to severe dehydration, the main cause of death in cholera cases, MSF has rehydration points conveniently located closer to communities than medical centers. Such rehydration points are effective in treating mild cholera cases.

Save The Children Offers Health Care

Since children with malnutrition are three times more likely to die from cholera, groups that provide nourishment in Yemen are essential. Save the Children, the first-ever international aid group in Yemen, not only distributes cash and food vouchers to families but also provides food for children and pregnant women.

Supporting 167 health facilities in Yemen, Save the Children provides training to health care professionals and volunteers in malnutrition management and prevention, a step taken to further alleviate the cholera crisis in Yemen.

Islamic Relief USA Provides Access to Clean Water

Islamic Relief USA works to provide vital aid, emergency food assistance and emergency water supply in the war-torn country. Clean water is vital to the country because cholera mainly spreads through contaminated drinking water. Islamic Relief USA is actively providing a clean supply of water to the governorates of Aden and Taiz. Both Taiz and Aden will have water tanks installed close to homes and schools so they remain water-secure when the organization is no longer active in these governorates. About 4,000 internally displaced people in these governorates will be at a decreased risk of cholera infection due to an increase of clean water supply from the water tanks.

The World Health Organization Increases Defenses Against Cholera

The World Health Organization maintains that Yemen is beginning to see a decrease in cholera infections. Financial aid from Saudi Arabia and the United Arab Emirates are contributing to this decrease. Millions of Yemenis now have access to health care unlike before. WHO is working on increasing the availability of diarrheal treatment centers, cholera vaccines and training of health providers in Yemen.

With 17.8 million water insecure people, Yemen is a breeding ground for cholera. Organizations like those listed above are essential to promoting prevention, care, and hopefully soon, the suppression of the cholera health crisis in Yemen.

– Rebekah Askew
Photo: Flickr

September 14, 2019
https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg 0 0 Kim Thelwell https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg Kim Thelwell2019-09-14 09:00:432024-06-06 00:26:26Cholera: Health Crisis in Yemen
Disease, Global Poverty, Health, Nonprofit Organizations and NGOs

The 5 Top Nonprofit Foundations

Top 5 Nonprofit Foundations
Throughout the world, millions of people face the development of disease. Many of these diseases are not yet curable, which has forced many to be fearful for their lives. Several organizations have come up with ways to fund research and provide information to those suffering from these diseases so that they can live longer and happier lives. These top 5 nonprofit foundations are among the many nonprofit organizations that have dedicated their lives to curing disease.

The March of Dimes Foundation

The March of Dimes Foundation is a U.S. nonprofit organization that works to improve the health of mothers and babies. Formed the day before World War II, the March of Dimes Foundation, formerly the National Foundation for Infantile Paralysis (NFIP), became very popular like its founder, Franklin D. Roosevelt. With the war in full effect, the Foundation was able to gain its rise through “radio, Hollywood and the personal appeal of the president.” The organization established the Office of Global Programs, that allowed worldwide partnerships with communities in Latin America, Europe and Asia bringing in prenatal education and care. The March of Dimes Global Network for Maternal and Infant Health has supported programs in China, Brazil, Lebanon, the Philippines, Malawi and Uganda.

United Way

United Way’s mission is to improve lives by mobilizing the caring power of communities around the world and advancing the common good. The organization collaborated with the Shanghai Charity Foundation to provide teacher training, a place for children to learn, educational toys and other learning materials for 20 kindergarteners. In 2010, the United Way worked with the Airbus Corporate Foundation to create the Flying Challenge, which encourages at-risk middle and high school students to stay in school. So far, the challenge has allowed more than 600 students from Wichita, Kansas to Getafe and Cadiz, Spain the opportunity to receive mentorship through the Flying Challenge initiative.

The Global Fund

Among the top 5 nonprofit foundations listed, the Global Fund is the newest organization to raise, manage and invest the world’s money towards infectious diseases. Since 2002, the Global Fund has focused on three infectious diseases; AIDS, TB and malaria. The organization has invested more than $4 billion a year to support programs in more than 100 countries. Many of these programs are occurring in countries within Eastern Europe, Central Asia, North Africa, the Middle East, Latin America, the Caribbean, the Pacific, and mainly, Sub-Saharan Africa.

The WHO

The World Health Organization formed in 1948 and is a specialized agency of the United Nations that is concerned with international public health. WHO has six regional offices, including its headquarters in Geneva, Switzerland. The WHO regional office in Africa and the Africa Centres for Disease Control and Prevention work together to end disease outbreaks and build stronger health systems. WHO has provided technical leadership in surveillance, vaccination and case management, and has deployed 700 international experts that respond to disease outbreaks. On July 2019, the Ministry of Health reported 2,620 Ebola cases with 1,762 deaths and 737 survivors.

UNAIDS

UNAIDS is the main advocate for accelerated, comprehensive and coordinated global action on the HIV/AIDS pandemic. Young women between the ages of 15 and 24 are more likely to obtain the virus. Four in five new infections in Sub-Saharan Africa among adolescents aged 15 to 19 years are girls. More than 35 percent of women around the world have experienced physical and/or sexual violence at some time in their lives. This makes it 1.5 times more likely for them to obtain HIV than women who have not experienced this form of violence. Towards the end of 2018, UNAIDS used $19 billion towards the AIDS response in low-and middle-income countries, which was $1 billion less than the previous year. UNAIDS believes that the AIDS response in 2020 will require $26.2 billion.

These top 5 nonprofit foundations have continued to raise money to fund research for cures that impact millions of people in the world. They have made it their responsibility to ensure that patients and their families gain the necessary care to gain power over their lives.

– Emilia Rivera
Photo: Flickr

September 11, 2019
https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg 0 0 Kim Thelwell https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg Kim Thelwell2019-09-11 09:00:312024-05-27 23:59:48The 5 Top Nonprofit Foundations
Global Poverty, Health

Promoting the HPV Vaccine in the Middle East to Prevent Cervical Cancer

HPV Vaccine in the Middle EastGlobalization opens up channels to foreign cultural trends and facilitate the free exchange of ideas between populations of different countries. Youth in more religiously and culturally conservative regions of the world are particularly influenced by foreign representations of sexual intercourse in pop culture. Tackling problems surrounding the HPV vaccine in the Middle East and North Africa is becoming more of an issue as young people are beginning to experiment more with sex but without the preventive measures taken by other countries to confront sexually transmitted diseases and the long-term consequences of exposure.

Regional Barriers to Preventive Measures

Since many people in the Middle East and North Africa associate the immunization of adolescents with STI-preventing vaccines with the presumption that adolescents are seeking sexual intercourse, religiously strict societies of this region fail to implement preventive sexual health measures such as HPV vaccinations and cervical cancer screenings. Common understanding suggests that these societies view the HPV vaccine as an infringement on long-standing cultural and religious practices and a foreign intrusion on regional values. However, this perception is largely shaped by key religious leaders and politicians who regulate public discourse and are viewed as possessing the authority to distinguish between what is morally right and wrong. In fact, contributors working on behalf of the Eastern Mediterranean Health Journal have discovered that most families in the Middle East and North Africa display an acceptance of STI-preventing vaccines and educative initiatives promoting sexual health.

Public View on the HPV Vaccine in the Middle East and North Africa

A study published by WHO in 2017 examined 18 studies pulled from the PubMed and Embase databases dated between January 2010 and April 2017 to ascertain the prevalence of the HPV vaccine in the countries composing the Arab World. The selected studies interviewed various groups and subgroups of national populations, including adolescent men and women, young men and women, women of various age groups, healthcare professionals and parents. Among a variety of questions probed were knowledge of the existence of an HPV vaccine and awareness of the causal link between HPV and cervical cancer. The question limited to this report address general acceptance of the HPV vaccine in the Middle East and North Africa.

The results were promising. Considering the religious composition of the Arab World, the non-secular identities of political bodies in Arab countries and the influence of religion on policymaking, 99 percent of Egyptian women, 91.3 percent of Bahraini women and 89.9 percent of Saudi women were accepting of the HPV vaccine. Rates of acceptability among women tended to be high in most Arab countries, although the lowest incidence was recorded by a study of Emirati women which showed an acceptability rate of 46 percent. The average acceptability rate for university men in the United Arab Emirates was 46 percent and a 2015 study in Morocco showed that 76.8 percent of mothers and 68.9 percent of fathers approved of immunizing their children with the HPV vaccine.

Promoting the HPV vaccine in the Middle East and North Africa

The national health organizations of many countries in the region are promoting an open discourse about sexual health and advocating for the institutionalization of vaccinations in public facilities such as schools. Cervical cancer remains among the top ten leading causes of death among women in Arab countries. Meanwhile, Israel possesses one of the lowest rates in the world. This could be due to the institutionalized vaccination system in the Israeli school system. However, Baruch Velan, a vaccination compliance researcher at the Gertner Institute for Health Policy and Epidemiology in Israel, cites that the HPV vaccine compliance rate is higher in the Arab population than in the Jewish population in Israel. Why Israel has such low rates of cervical cancer, especially compared to other countries in the region, is unknown.

The changing views toward the HPV vaccine in the Middle East and North Africa shows that there is hope to increase vaccinations and decrease rates of cervical in the region.

– Grayson Cox
Photo: Flickr

September 10, 2019
https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg 0 0 Kim Thelwell https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg Kim Thelwell2019-09-10 14:24:332019-09-28 10:02:53Promoting the HPV Vaccine in the Middle East to Prevent Cervical Cancer
Global Poverty, Health

How Chlorhexidine is Lowering Infant Mortality

ChlorhexidineAn estimated 390,000 babies die within their first months of life annually due to severe infections. For the past decade or so, USAID has been combating this number with a low-cost yet highly effective antiseptic called Chlorhexidine. The chemical is typically used in hospitals to either disinfect the skin before a surgery or to sterilize surgical equipment, but USAID says that the antiseptic “can also be used to protect the umbilical stumps of newborns to prevent life-threatening complications from an infection.” These infections, USAID explains, can in part be a regular consequence of the traditional home birthing practices found in poorer countries. After conducting multiple studies, it has been shown that even a “one-time chlorhexidine treatment can lower the risk of severe infection [in infants] by 68 percent and infant death by 23 percent.”

Countries Adopting Chlorhexidine

Because it is relatively cheap, easy to manufacture and proven to be effective, around 30 nations throughout Africa and Asia either expressed interest in the antiseptic or have begun working with USAID to integrate the antiseptic into their healthcare system over the past several years.

Case Study: Nepal

Nepal was the first nation to implement the treatment back in 2011. It has since reduced the likelihood of infant illness and mortality by 34 percent. The success in Nepal is what inspired a chain-reaction that lead to the antiseptic being adopted into a variety of different countries—but the success of the disinfectant did not come without its challenges.

Before Chlorhexidine was initiated into their health system, the World Health Organization (WHO) recommended that the nation adopt a dry care system to treat the umbilical cord; this system required that the mother keep her child’s umbilical stump clean and dry until the stump fell off on its own while she kept an eye out for any signs of infection.

Due to cultural barriers, this suggestion was not followed. USAID said that mothers in Nepal had been used to routinely applying unsanitary substances such as turmeric, ash, cow dung or a mercury-based red cosmetic powder used by Hindu women to the umbilical stump by hand. Thankfully Nepal has been impressed with the results Chlorhexidine has supplied but the earlier setbacks in treatment shed an important light for USAID and its partners on how complex assimilating a scientifically safe treatment into impoverished nation’s culture can actually be.

Today, both single-dose tubes of the antiseptic are freely distributed to all expecting mothers in their eighth month of pregnancy and a one-on-one training session explaining how to safely apply the gel after cutting the umbilical cord.

Case Study: Pakistan

Pakistan implemented the treatment in 2014. Pakistan reportedly has the third-highest newborn mortality rate in the world, with umbilical cord infections serving as the second leading cause of death to Pakistani newborns. Seeing as Pakistan is a much larger and complex country, it faced a different set of challenges than Nepal when it came to making the antiseptic widespread.

There were some cultural barriers to overcome in Pakistan as well—many Pakistani women used to treat umbilical cords with surma, a lead-based concoction)—but the main challenge the nation had to overcome was to bring together all the government and private offices working towards a Chlorhexidine treatment program independently. To convene all of these health offices together and collaborate on an implementation plan was no small feat and took around a full year, and then the plans were formally adopted another year later, in 2016.

Of course, Chlorhexidine comes with its own set of risks. Although it has been found to reduce infections, it has also been discovered to cause rashes and burns on some skin types. Even so, the use of Chlorhexidine in both Nepal and Pakistan shows that although the process of assimilating treatment is not always easy or quick, it yields hopeful results that encourage nations in the surrounding areas to adopt the life-saving drug as well.

– Haley Hiday
Photo: Flickr

September 9, 2019
https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg 0 0 Kim Thelwell https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg Kim Thelwell2019-09-09 09:39:222024-05-27 23:53:49How Chlorhexidine is Lowering Infant Mortality
Global Poverty, Health

An Analysis of Healthcare Systems in Togo

healthcare systems in Togo

Togo, a country located in West Africa is occupied by eight million people and currently faces a healthcare crisis. Nations across the globe have been successful in transforming inadequate healthcare systems into those that successfully prevent and treat ailments. That said, according to a 2017 story by Development and Cooperation, Togo is often referred to as having the worst health systems in West Africa.

Many factors contribute to the sub-par healthcare systems in Togo, including insufficient staff, outdated medical instruments and practices, and ineffective financial and insurance resources. These components combine to create the current healthcare system in Togo.

Despite this complicated health matrix, efforts have been made by the government in tandem with non-governmental organizations (NGOs) to reduce the burden of disease and to improve the healthcare systems in Togo.

Diagnosing the Problem

According to a story run by Deutsche Welle (DW), a German international broadcaster, Togo only sports three healthcare workers for every 10 thousand residents, which DW claims is approximately a quarter of the number of healthcare workers per 10 thousand residents for Ghana. Insufficient staff across the nation – not only in the larger centralized hospitals of Togo, contribute to the poor health systems present.

Inadequate staffing at clinics and hospitals alike can escalate quickly. Lack of properly trained and licensed doctors, nurses and medical personnel often leads to overcrowding in emergency and waiting rooms alike, which complicates matters further. Keeping patients awaiting treatment in confined places increases disease transmission between patients, especially those that can be transferred via skin contact and via the air. Furthermore, the same 2017 Development and Cooperation story recounted several instances where patients tragically passed away while awaiting treatment in some of Togo’s largest hospitals.

In addition to overwhelmed and insufficient staffing, the hospitals themselves are not properly stocked with the supplies necessary to diagnose and treat incoming patients. Outdated medical instruments and practices also have the potential to contribute to inadequate healthcare systems in Togo. Equipment may become faulty over time, or the technology used may simply just not be correct.

While outdated medical technologies are certainly lacking, hospitals also appear to lack basic amenities such as beds. In 2011, Togo only sported seven hospital beds per 10,000 population.

Insufficient staffing and medical supplies seemingly stem from one arena, however: lack of financial resources available. As of 2015, over 55 percent of Togo’s population lived under the global poverty line – approximately four million people. Because of this extreme poverty, patients cannot afford the necessary treatments which leads to a lack of funding for hospitals, resulting in smaller staff and inadequate supplies.

As of right now, healthcare systems in Togo seem to operate on a “pay or die” approach, according to the Development and Cooperation story. Patients and loved ones of those who have fallen ill often have to borrow money in an effort to receive treatment for diseases and ailments. Even then, sometimes it is not enough.

Current Remedies

Global efforts have been to improve the inadequate healthcare systems in Togo. Currently, Togo is in the midst of a five-year project aimed at ending neglected tropical diseases (NTDs). This integrated NTD control currently receives funding from The Bill & Melinda Gates Foundation, The Liverpool School of Tropical Medicine, and both the World Health Organization (WHO) and the United Nations International Children’s Emergency Fund (UNICEF) among others.

This funding goes directly to combatting and administering diagnoses and treatments for neglected tropical diseases present in Togo. Furthermore, a significant portion of the funds dedicated to reducing the burden of these NTDs in Togo is allocated toward the training of health workers, hopefully providing stability in the healthcare sector for years to come.

Aside from these efforts to combat NTDs, other global institutions have made efforts to improve Togo’s healthcare system in general.

The International Association of National Public Health Institutes (IANPHI), an institution set on improving healthcare systems and structures using peer-to-peer models, has begun to lay the groundwork for strengthening the healthcare systems in Togo. Much of IANPHI’s work goes toward strengthening disease surveillance, as well as equipping Togo’s Ministry of Health with laboratory and research facilities, hopefully promoting new science and health-related job opportunities.

Moving Forward

The healthcare systems in Togo have a significant and difficult path in front of them. The issues of staffing, supplies and financial insecurities must be addressed in order to increase health promotion and disease prevention in the country. That said, significant progress has been made in laying the groundwork of the future of Togo’s healthcare systems, hopefully paving the way for significant reform and a brighter future.

– Colin Petersdorf
Photo: Flickr

September 7, 2019
https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg 0 0 Kim Thelwell https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg Kim Thelwell2019-09-07 16:16:222024-05-29 23:10:55An Analysis of Healthcare Systems in Togo
Global Poverty, Health

VISION 2020 Initiative

VISION 2020 initiativeBlindness, as well as moderate to severe visual impairments (MSVI), affects hundreds of millions of people around the world. An estimated 217 million people suffer from MSVI, and 36 million are blind. However, despite the fact that 89 percent of all visually impaired people live in developing countries, blindness tends to be one of the more overlooked aspects of anti-poverty and development efforts around the world.

In 1999, the World Health Organization (WHO), in partnership with more than 20 other organizations, launched the VISION 2020: The Right to Sight campaign, which intended to “eliminate the main causes of all preventable and treatable blindness as a public health issue by the year 2020.” Since the beginning of the campaign, much progress has been made in reducing preventable blindness around the world. However, preventable blindness continues to be an issue around the world, particularly in impoverished countries.

Before diving into the origins, objectives and accomplishments of the VISION 2020 initiative, it will be useful to understand how blindness, MSVI and global poverty intersect.

Blindness and Global Poverty

Due to the fact that the overwhelming majority of blind and visually impaired people live in poor and middle-income countries, poor eye health has become deeply intertwined with global poverty. In general, blindness and MSVI are common among the global poor because of their inability to afford health services, which puts them at an increased risk of contracting eye diseases. Additionally, a lack of awareness about eye health exacerbates this problem.

Unfortunately, poverty can cause blindness just as much as blindness can cause poverty. Blindness can impose severe economic burdens on those affected by drastically reducing their ability to work and provide for themselves. Ninety percent of blind people around the world cannot work. High levels of blindness also create economic problems for whole countries, and even the world economy. In 2000, it was estimated that visual impairment cost the global economy between $19,223 million and $22,764 million in GDP.

Blindness can also bring negative social consequences, such as a loss of social standing and authoritative decision-making. This social stigma is particularly prevalent in blind women, 80 percent of whom report a loss of authority within their families. Additionally, the economic impact of blindness can lead the afflicted to feel an increased sense of social isolation and alienation from their communities.

The VISION 2020 Initiative

The VISION 2020 initiative is a multi-organization campaign, launched by the WHO in 1999, which aims to eliminate preventable blindness by the year 2020. In order to achieve this goal, VISION 2020 has used three core strategies. These include using specific programs to control and treat the major causes of blindness, training ophthalmologists and other eye doctors to provide eye care to those who need it, and improving technology and infrastructure to increase the accessibility of eye treatment.

Since the VISION 2020 initiative launched, some progress has undeniably been made toward reducing preventable blindness worldwide. Between 1999 and 2015, the prevalence of visual impairment decreased from 4.58 percent to 3.38 percent. Additionally, many low and middle-income countries are seeing increased rates of cataract surgery.

However, despite the fact that the campaign is in its final year, it will not achieve its goal of ending preventable blindness around the world. Compounding this problem, researchers are pointing to emerging global health trends that are expected to cause an increase in visual impairments around the world. For example, an increase in the elderly population will likely give rise to an increase in age-related visual impairments, like cataracts. Increased rates of diabetes around the world are causing higher rates of diabetic retinopathy.

It is important to recognize that while these health developments may complicate efforts to reduce blindness worldwide, the fact that researchers have knowledge of these trends can shape the strategies of future anti-blindness campaigns. Despite the failure of the VISION 2020 initiative to end preventable blindness around the world, experts can learn from the program’s shortcomings and build on its successes going forward.

– Andrew Bryant
Photo: Flickr

September 5, 2019
https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg 0 0 Kim Thelwell https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg Kim Thelwell2019-09-05 16:21:232024-05-29 23:10:56VISION 2020 Initiative
Developing Countries, Global Poverty, Health

Pharmaceuticals Providing Affordable Medicine in Developing Countries

Affordable Medicine in Developing Countries
In 1997, thousands of people in low-income, developing countries died every day from treatable diseases because they could not pay the high price pharmaceuticals charged for medicine. Today in these same regions, millions are receiving treatment and mortality rates have dropped dramatically as drugmakers around the world are providing affordable medicine in developing countries.

Pharmaceuticals in the Past

In 1997, AIDS was killing thousands of Africans each day. In the same year, people with AIDS in the U.S. were enjoying greater life expectancy and quality of life, with AIDS-related deaths dropping by 42 percent thanks to the use of anti-HIV drugs.  With a $12,000 per patient per year price tag and strict patent laws forbidding the purchase of generic types, these life-saving drugs were inaccessible to millions of AIDS victims in developing countries. Unwilling to lower their prices, the pharmaceutical industry looked on while thousands of people died with treatment just beyond their reach.

Refusing to sit by as its people died every day while a treatment existed, South Africa legalized the suspension of drug patents in 1998, making it possible for South Africans to purchase generic anti-HIV drugs at affordable prices. Thirty-nine top pharmaceutical companies promptly engaged South Africa in a lawsuit, attempting to keep them from accessing HIV drugs at a reduced cost for fear that other countries would follow and the industry would miss out on profits.

The pharmaceuticals soon dropped the lawsuit when the international community received word that drug companies were keeping poor and dying people required medicines. However, drug prices remained inaccessibly high.

Finally, a turning point came in 2001 when Indian drug-maker Cipla shocked the international pharmaceutical industry by announcing its plan to sell anti-HIV drugs directly to poor nations and to Doctors Without Borders for only $350 per patient per year (less than $1 a day). Cipla’s offer exposed the huge markups pharmaceutical companies were profiting from, prompting several major drug-makers to lower their prices and make drugs more accessible to developing countries.

Pharmaceuticals Today

Today, the pharmaceutical industry’s attitude and approach toward providing affordable medicine in developing countries have greatly shifted. The Access to Medicine Foundation shares that nearly all major drug companies have goals for addressing access to medicine now, while many have pioneered innovative ways to reduce costs and create medicines and vaccines for low- and middle-income countries (LMICs). In the past 10 years, drug makers have doubled the number of medicines they are developing for LMICs.

Nine companies that own patents for HIV/AIDS treatment now use their IP rights flexibly to allow LMICs to import and purchase generic supplies. As a result, over 14 million Africans are now on HIV drugs, and AIDS-related deaths dropped drastically by nearly 40 percent over the past 10 years.

Seven drug companies have made efforts to include the poorest populations in their customer base, focusing on products for diabetes, heart disease and other NCDs which are a rising problem in the developing world. In 2017, the leading drug maker, Pfizer, partnered with Cipla to sell chemotherapy drugs to African countries at prices just above their own manufacturing cost, selling some pills for as little as 50 cents.

Several leading pharmaceuticals now partner with generics to produce affordable drugs for Africa, Asia and Latin America, and a fair price strategy now covers 49 percent of products. Thanks to the improvements in the pharmaceutical industry, hundreds of thousands of people now have access to affordable medicine in developing countries.

– Sarah Musick
Photo: Wikimedia Commons

 

September 4, 2019
https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg 0 0 Kim Thelwell https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg Kim Thelwell2019-09-04 09:23:322024-05-29 23:10:13Pharmaceuticals Providing Affordable Medicine in Developing Countries
Children, Development, Education, Food & Hunger, Global Health, Global Poverty, Health, Life Expectancy

10 Facts About Life Expectancy in Chile

Life Expectancy in Chile
Located on the southwest edge of South America, Chile‘s international poverty rate is 1.3 percent. This number is fairly low compared to other nations, but Chilean poverty is on the rise as the nation’s international poverty rate increased from 0.9 percent in 2015. Today, 234,083 Chilean people remain impoverished and currently survive on less than $1.90 a day. Despite this descent in economic prosperity, poverty has not negatively affected the country’s life expectancy as it is has risen from 73.6 in 1990 to 79.1 in 2018. Here are 10 facts about life expectancy in Chile.

10 Facts About Life Expectancy in Chile

  1. Female Life Expectancy: While the overall average life expectancy in Chile evens out at 79.1 years, according to the Central Intelligence Agency (CIA), women tend to live longer. Women have an average lifespan of 82.2 years while most men live to the age of 76. Despite this gap in longevity, Chilean citizens generally live long lives as the country ranks 51st among 222 other global nations.
  2. Living Conditions: Overcrowding has long been an issue in Chile. Not only does it reflect the economic fragility of the region but it also harms the physical and mental health of citizens subjected to it. When the Chilean government implemented the Social Housing Recovery of 2014, the health of the country’s citizens increased and their life expectancy increased as a result. Today, the average Chilean home houses 1.2 people per room, which is better than the Organisation for Economic Co-operation and Development’s (OECD) average of 1.8. Thanks to the Social Housing Recovery initiative, Chileans not only experience a higher standard of living, but they also received their right to better health and longer lives.
  3. Obesity: Obesity is one of Chile’s leading health issues. According to the CIA, nearly one-third of all Chilean adults suffer from obesity. Chile’s obesity rates ranked number 32 globally with 34.4 percent of adults and 44.5 percent of children suffering from the condition. Because of obesity, a large number of the nation’s citizens have an increased risk of other diseases including cardiovascular diseases, cancer and diabetes, some of the nation’s leading causes of death.
  4. Public Health Interventions: The Bono Auge Programme of 2010 created a universal health care program for Chile’s people. By providing a private health care voucher when public sector care is unavailable, more Chilean citizens are able to receive health care. Following its implementation, the program reduced the patient waiting list by 113,556 in 2010 to 50,780 the following year. The program also prioritizes those with high mortality pathological conditions and sets a two-day time limit on their waiting period for care. Patients who do not see a health care provider in this time frame receive a voucher so that another provider will see them. Equal health care increases the life expectancy of the Chilean people, as faster care and treatment not only saves lives but also extends them.
  5. Cancer: According to the OECD, Chile’s cancer mortality rate is high in comparison with its level of occurrence. Of the 35 percent of cases diagnosed, 23.8 percent end in death. This number makes up 24 percent of Chile’s national mortality rate and shortens the expected life span of its people. While the country has ways to treat the disease, much of this treatment is unequal and not enough. While it has created good screening procedures for cervical and breast cancers, it lacks large quantities of the equipment necessary to perform the job. Consequently, it is unable to reach a large number of people, and many people’s cancers go undetected. Unequal and limited proper testing hold Chile’s life expectancy back, as many of the country’s people die of cancers they are not aware they even have.
  6. Child Mortality: Ranked 163 in comparison with other countries, Chile’s infant mortality rate is fairly low. With an average of 6.4 deaths per 1,000 births and an under-5 mortality rate of 7.4 out of 1,000 during 2017, the country’s numbers prove themselves unalarming. Also, Chile’s infant mortality rate is on the decline, as the country’s under-5 mortality has dropped from 33.10 in 1980 to 7.4 in 2017.
  7. Air Pollution: Chile’s high concentration of air pollutant particles has a negative effect on the nation’s life expectancy. With 16.03 micrograms per cubic meter polluting Chilean air, the country fails to meet the 10 microgram standard that the World Health Organization set. The issue with polluted air is that it increases the risk for other diseases, such as lung cancer, which can eventually lead to death. Also, many expect that polluted air will be the leading cause of environmental premature death by 2050, meaning that without intervention, the country’s air quality will not only shorten the lives of people in the present, but it will also hurt the citizens of Chile’s future.
  8. Access to Health Care: While Chile has made strides towards equalizing its health care, care inequality is still a large issue. Socioeconomic status is the main determinant of the amount and quality of health care Chilean citizens receive. Chile’s indigenous citizens are statistically more impoverished, as they have a 35.6 percent poverty rate in comparison to their non-indigenous counterparts whose poverty rate rests at 22.7 percent. With a lower economic status, indigenous individuals have a higher risk of death, especially within their first year of life. In Mapuche, Chile, the children indigenous to Araucania have a 250 percent higher risk of death in their first year than those non-indigenous to the region. Without proper and equal access to health care, Chile’s impoverished people have a lower life expectancy merely because of economic status.
  9. Tobacco Consumption: According to the Pan American Health Organization, 20.2 percent of Chilean adolescents aged 19 to 25 participate in tobacco use. This number rises to 49.1 percent when assessing those citizens aged 26 to 34. This popularity in tobacco use not only increases the country’s risk of death from lung-related diseases, but it accounts for a large chunk of its lung cancer diagnoses. Chile is doing work to combat the issue, as it has implemented many anti-smoking policies, such as prohibiting smoking in public. As a result of these legislations, the prevalence of the nation’s total tobacco use has decreased from 42.6 percent in 2006 to 34.7 percent in 2014.
  10. Maternal Mortality: As of 2014, parasites and infections are the largest contributors to maternal deaths in Chile, as they make up to 25 percent of the total causes. While the maternal mortality rate has decreased, as deaths per 100,000 live births have dropped from 39.9 in 1990 to 22.2 in 2015. Improving Chilean poverty and prioritizing Chilean health care would improve the maternal death rate even more, as parasitic and infectious diseases are more prevalent among poverty-stricken regions.

These 10 facts about life expectancy in Chile show that by working towards ending Chilean poverty, the country’s total life expectancy will rise as a result. With poverty increasing the risk of many factors that contribute to Chilean mortality, such as decreased access to health care, reduced health literacy, higher risk of disease and higher prevalence of destructive behavior, a fight against poverty is a fight for all Chilean life.

– Candace Fernandez
Photo: Flickr

September 3, 2019
https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg 0 0 Kim Thelwell https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg Kim Thelwell2019-09-03 15:39:552024-05-29 23:12:2710 Facts About Life Expectancy in Chile
Food & Hunger, Global Poverty, Health, Hunger

What is Hunger?

What is Hunger?
Every day, people around the world experience those familiar sensations of emptiness and rumbling pangs in their stomach, signaling that it is time to eat. At this point, most people would get something to eat and go on with their day. Sadly, many people in the world, especially those in developing countries, do not receive this luxury. They experience chronic hunger, which is undernourishment from not ingesting enough energy to lead a normal, active life. It is difficult to empathize with what hunger feels like, to live with a body longing for nourishment, weakened by a lack of energy and unable to fulfill its basic need for food.

According to the Food and Agriculture Organization (FAO) of the United Nations, an estimated one in nine people, 821 million, live with chronic hunger. It also states that the number of people living with the condition has been on the rise since 2014, with a staggering 98 percent living in developing countries.

The Consequences of Hunger

Hunger brings along with it many problems other than an aching stomach. Prolonged lack of adequate nourishment results in malnutrition, which causes the stunting of growth and development in children and wasting syndrome. Wasting syndrome is a side effect of malnutrition, in which the victim’s fat and muscle tissues break down to provide the body with nourishment. The condition results in an emaciated body and in some cases, death. In fact, malnutrition links to around 45 percent of deaths among children under the age of five, according to the World Health Organization (WHO).  Fortunately, some have made progress. Since 2012, the number of stunted children in the world has decreased by nine percent from 165.2 million to 150.8 million, a significant improvement.

Hunger and Poverty

Poverty is the underlying determinant in who suffers from chronic hunger. Impoverished people are unable to consistently provide substantial amounts of food for themselves or their families, as they simply cannot afford to. This inability to provide nourishment creates a vicious cycle of hunger and poverty.

Undernourished people lack the energy required to perform basic tasks and therefore are less productive. Those who were malnourished as children develop stunted physical and intellectual abilities, which results in a reduction in the level of education achieved and the individual’s income, according to UNICEF.

What Can People Do?

People can break this vicious cycle and help people suffering from chronic hunger. Organizations such as The Hunger Project, the FAO and the Gates Foundation all have initiatives aimed at helping those in need get on their feet.

The Hunger Project works to empower those suffering from hunger with the tools they need to become self-reliant.  In Mbale, Uganda, the organization partnered with the local community to build a food bank where farmers are able to safely store grain, which has greatly increased their food security.

The FAO focuses on aiding governments and other organizations in implementing initiatives that aim to decrease hunger and malnourishment. A great example of this is Africa Sustainable Livestock 2050, in which the FOA helps countries such as Kenya and Ethiopia develop livestock infrastructure that will support the countries as their populations increase over the coming years.

Bill and Melinda Gates formed the Gates Foundation in 2000 with the main focus of providing internet to those who do not have access to it. Since then, the scope of the foundation’s mission has expanded to help the impoverished through global health and development initiatives. One of the foundation’s major initiatives is Seed Systems and Variety Improvement, which aims to improve seed breeding systems in Africa and India in an effort to make agriculture in those countries more sustainable.

With projects that aim to give impoverished people access to clean water, infrastructure, sustainable farming, disaster relief and education, these organizations have made significant strides.

Individuals can help eradicate chronic hunger by donating to charitable organizations or by contacting their government representatives, encouraging them to support bills and initiatives that aim to combat global hunger. Everyone can play a role and spread the word. There is a long road ahead, but with the tools available, chronic hunger can become a thing of the past.

– Shane Thoma
Photo: Flickr

September 3, 2019
https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg 0 0 Kim Thelwell https://borgenproject.org/wp-content/uploads/borgen-project-logo.svg Kim Thelwell2019-09-03 05:45:122024-05-29 23:09:55What is Hunger?
Page 133 of 214«‹131132133134135›»

Get Smarter

  • Global Poverty 101
  • Global Poverty… The Good News
  • Global Poverty & U.S. Jobs
  • Global Poverty and National Security
  • Innovative Solutions to Poverty
  • Global Poverty & Aid FAQ’s
Search Search

Take Action

  • Call Congress
  • Email Congress
  • Donate
  • 30 Ways to Help
  • Volunteer Ops
  • Internships
  • Courses & Certificates
  • The Podcast
Borgen Project

“The Borgen Project is an incredible nonprofit organization that is addressing poverty and hunger and working towards ending them.”

-The Huffington Post

Inside The Borgen Project

  • Contact
  • About
  • Financials
  • President
  • Board of Directors
  • Board of Advisors

International Links

  • UK Email Parliament
  • UK Donate
  • Canada Email Parliament

Get Smarter

  • Global Poverty 101
  • Global Poverty… The Good News
  • Global Poverty & U.S. Jobs
  • Global Poverty and National Security
  • Innovative Solutions to Poverty
  • Global Poverty & Aid FAQ’s

Ways to Help

  • Call Congress
  • Email Congress
  • Donate
  • 30 Ways to Help
  • Volunteer Ops
  • Internships
  • Courses & Certificates
  • The Podcast
Scroll to top Scroll to top Scroll to top